Spatial Approximation between Secretin Residue Five and the Third Extracellular Loop of Its Receptor Provides New Insight into the Molecular Basis of Natural Agonist Binding
暂无分享,去创建一个
[1] H. Kofod. Synthesis of biologically active porcine secretin and [ITyr10] porcine secretin. , 2009, International journal of peptide and protein research.
[2] L. Miller,et al. Use of N,O-bis-Fmoc-D-Tyr-ONSu for introduction of an oxidative iodination site into cholecystokinin family peptides. , 2009, International journal of peptide and protein research.
[3] R. Abagyan,et al. Fluorescence Resonance Energy Transfer Analysis of Secretin Docking to Its Receptor , 2007, Journal of Biological Chemistry.
[4] R. Rudolph,et al. Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor , 2007, Proceedings of the National Academy of Sciences.
[5] R. Abagyan,et al. Molecular Approximations between Residues 21 and 23 of Secretin and Its Receptor: Development of a Model for Peptide Docking with the Amino Terminus of the Secretin Receptor , 2007, Molecular Pharmacology.
[6] P. Hajduk,et al. Solution structure and mutational analysis of pituitary adenylate cyclase-activating polypeptide binding to the extracellular domain of PAC1-RS , 2007, Proceedings of the National Academy of Sciences.
[7] R. Riek,et al. Structure of the N-terminal domain of a type B1 G protein-coupled receptor in complex with a peptide ligand , 2007, Proceedings of the National Academy of Sciences.
[8] Y. Asmann,et al. Possible Endogenous Agonist Mechanism for the Activation of Secretin Family G Protein-Coupled Receptors , 2006, Molecular Pharmacology.
[9] L. Miller,et al. Use of Probes with Fluorescence Indicator Distributed throughout the Pharmacophore to Examine the Peptide Agonist-binding Environment of the Family B G Protein-coupled Secretin Receptor* , 2006, Journal of Biological Chemistry.
[10] R. Abagyan,et al. Pocketome via Comprehensive Identification and Classification of Ligand Binding Envelopes* , 2005, Molecular & Cellular Proteomics.
[11] Richard R. Neubig,et al. International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List , 2005, Pharmacological Reviews.
[12] R. Riek,et al. NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[13] L. Miller,et al. Molecular Approximation between a Residue in the Amino-terminal Region of Calcitonin and the Third Extracellular Loop of the Class B G Protein-coupled Calcitonin Receptor* , 2004, Journal of Biological Chemistry.
[14] T. Lybrand,et al. Spatial Approximation between the Amino Terminus of a Peptide Agonist and the Top of the Sixth Transmembrane Segment of the Secretin Receptor* , 2004, Journal of Biological Chemistry.
[15] L. Miller,et al. Importance of the Amino Terminus in Secretin Family G Protein-coupled Receptors , 2004, Journal of Biological Chemistry.
[16] Darrell R. Abernethy,et al. International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.
[17] T. Lybrand,et al. Spatial Approximation between Two Residues in the Mid-region of Secretin and the Amino Terminus of Its Receptor , 2003, Journal of Biological Chemistry.
[18] T. Lybrand,et al. Erratum: Spatial approximation between a photolabile residue in position 13 of secretin and the amino terminus of the secretin receptor (Molecular Pharmacology (2003) 63 (993-1001)) , 2003 .
[19] H. Schiöth,et al. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. , 2003, Molecular pharmacology.
[20] T. Lybrand,et al. Spatial approximation between a photolabile residue in position 13 of secretin and the amino terminus of the secretin receptor. , 2003, Molecular pharmacology.
[21] T. Lybrand,et al. Interaction among four residues distributed through the secretin pharmacophore and a focused region of the secretin receptor amino terminus. , 2002, Molecular endocrinology.
[22] Y. Asmann,et al. Identification of Two Pairs of Spatially Approximated Residues within the Carboxyl Terminus of Secretin and Its Receptor* , 2000, The Journal of Biological Chemistry.
[23] L. Miller,et al. Identification of an Interaction between Residue 6 of the Natural Peptide Ligand and a Distinct Residue within the Amino-terminal Tail of the Secretin Receptor* , 1999, The Journal of Biological Chemistry.
[24] T. Frimurer,et al. Structure of the integral membrane domain of the GLP1 receptor , 1999, Proteins.
[25] L. Miller,et al. Demonstration of a Direct Interaction between Residue 22 in the Carboxyl-terminal Half of Secretin and the Amino-terminal Tail of the Secretin Receptor Using Photoaffinity Labeling* , 1999, The Journal of Biological Chemistry.
[26] L. Suva,et al. Parathyroid Hormone-Receptor Interactions Identified Directly by Photocross-linking and Molecular Modeling Studies* , 1998, The Journal of Biological Chemistry.
[27] L. Miller,et al. Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors. , 1998, Gastroenterology.
[28] T. Lybrand,et al. Direct Identification of a Distinct Site of Interaction between the Carboxyl-terminal Residue of Cholecystokinin and the Type A Cholecystokinin Receptor Using Photoaffinity Labeling* , 1997, The Journal of Biological Chemistry.
[29] J. Vilardaga,et al. The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptors , 1996, Peptides.
[30] L. Miller,et al. Relationship Between Native and Recombinant Cholecystokinin Receptors: Role of Differential Glycosylation , 1996, Pancreas.
[31] J. Vilardaga,et al. Interaction of amino acid residues at positions 8-15 of secretin with the N-terminal domain of the secretin receptor. , 1996, European journal of biochemistry.
[32] L. Miller,et al. Multiple Extracellular Loop Domains Contribute Critical Determinants for Agonist Binding and Activation of the Secretin Receptor* , 1996, The Journal of Biological Chemistry.
[33] C. Sander,et al. Errors in protein structures , 1996, Nature.
[34] Y. Cao,et al. The amino-terminal fragment of the adenylate cyclase activating polypeptide (PACAP) receptor functions as a high affinity PACAP binding domain. , 1995, Biochemical and biophysical research communications.
[35] L. Miller,et al. Critical Contributions of Amino-terminal Extracellular Domains in Agonist Binding and Activation of Secretin and Vasoactive Intestinal Polypeptide Receptors. STUDIES OF CHIMERIC RECEPTORS (*) , 1995, The Journal of Biological Chemistry.
[36] Ruben Abagyan,et al. ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation , 1994, J. Comput. Chem..
[37] H. Jüppner,et al. The extracellular amino-terminal region of the parathyroid hormone (PTH)/PTH-related peptide receptor determines the binding affinity for carboxyl-terminal fragments of PTH-(1-34). , 1994, Endocrinology.
[38] R. Abagyan,et al. Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. , 1994, Journal of molecular biology.
[39] L. Miller,et al. Intrinsic photoaffinity labeling of native and recombinant rat pancreatic secretin receptors. , 1993, Gastroenterology.
[40] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .
[41] A. Gronenborn,et al. Determination of the backbone conformation of secretin by restrained molecular dynamics on the basis of interproton distance data. , 1988, European journal of biochemistry.
[42] L. Miller,et al. Analysis of the carbohydrate composition of the pancreatic plasmalemmal glycoprotein affinity labeled by short probes for the cholecystokinin receptor. , 1987, The Journal of biological chemistry.
[43] D Rodbard,et al. Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.
[44] J. Holst,et al. Secretin and Vasoactive Intestinal Polypeptide in the Control of the Endocrine Pancreas1 , 1980 .
[45] F. Sanger,et al. DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[46] J. Gardner,et al. Interaction of synthetic 10-tyrosyl analogues of secretin with hormone receptors on pancreatic acinar cells. , 1977, Gastroenterology.
[47] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[48] N. Metropolis,et al. Equation of State Calculations by Fast Computing Machines , 1953, Resonance.
[49] R. Stevens,et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. , 2007, Science.